According to Prothena's latest financial reports and stock price the company's current number of shares outstanding is 53,668,000. At the end of 2023 the company had 53,668,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 53.66 M | 9.62% |
2022 | 48.96 M | 5.02% |
2021 | 46.61 M | 16.78% |
2020 | 39.92 M | 0.06% |
2019 | 39.89 M | 0.08% |
2018 | 39.86 M | 3.66% |
2017 | 38.45 M | 11.13% |
2016 | 34.6 M | 9.47% |
2015 | 31.61 M | 15.44% |
2014 | 27.38 M | 28% |
2013 | 21.39 M | 43.72% |
2012 | 14.88 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Amarin Corporation
AMRN | 408,417,000 | 661.01% | ๐ฎ๐ช Ireland |
Alnylam Pharmaceuticals
ALNY | 125,220,000 | 133.32% | ๐บ๐ธ USA |
Alkermes ALKS | 166,607,000 | 210.44% | ๐ฎ๐ช Ireland |